Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Advanced Midgut Carcinoid Tumors
NCT01731925Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Jan 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sunitinib in midgut carcinoid tumor, sponsored by GERCOR. Status: unknown.
02
Drugs
sunitinib
03
Conditions
midgut carcinoid tumor
Beyond the preview
Go deeper on NCT01731925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01731925.